Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B

Cytokine

Volumn 61, Issue 3, 2013, Pages 940-944

  Conde, Simone R S ^a,b   Feitosa, Rosimar N M ^a   Freitas, Felipe Bonfim ^a   Hermes, Renata B ^a   Demachki, Samia ^b   Araújo, Marialva T F ^c   Soares, Manoel C P ^c   Ishak, Ricardo ^a   Vallinoto, Antonio C R ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Fundação Faculdade Federal de Ciências Médicas de Porto Alegre   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Chronic hepatitis B; Cytokine gene polymorphisms; Cytokine serum levels

Indexed keywords

DNA; GAMMA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIMPLE SEQUENCE REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD;

CASE-CONTROL STUDIES; CYTOKINES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875378734     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.01.004     Document Type: Article

References (35)

1. Alter M.J. Epidemiology and prevention of hepatitis B. Semin Liver Dis 2003, 23:39-46.
2. Pungpapong S., Kim R.W., Poterucha J.J. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007, 82:967-975.
3. Fattovich G., Bortolotti F., Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008, 48:335-352.
4. McMahon B.J. Natural history of chronic hepatitis B - clinical implications. Medscape J Med 2008, 10:91.
5. Feld J.J., Heathcote J. Hepatitis B e antigen-positive chronic Hepatitis B: natural history and treatment. Semin Liver Dis 2006, 26:116-129.
6. Lin C.L., Kao J.H. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 2008, 15:137-145.
7. Wong G.L.H., Wong V.W.S., Choi P.C.L., Chan A.W.H., Chim A.M.L., Yiu K.K.L., et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009, 58:111-117.
8. Bertoletti A., Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 2006, 87:1439-1449.
9. Baumert T.F., Thimme R., von Weizsäcker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007, 13:82-90.
10. Webster G.J.M., Reignat S., Maini M.K., Whalley S.A., Ogg G.S., King A., et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000, 32:1117-1124.
11. Thimme R., Wieland S., Steiger C., Ghrayeb J., Reimann K.A., Pucell R.H., et al. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003, 77:68-76.
12. Ohta A., Sekimoto M., Sato M., Koda T., Nishimura S., Pucell R.H., et al. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. J Immunol 2000, 15:956-961.
13. Vierling J.M. The immunology of hepatitis B. Clin Liver Dis 2007, 11:727-759.
14. Larrubia J.R., Benito-Martínez S., Miquel-Plaza J., Sanz-De-Villalobos E., González-Mateos F., Parra T. Cytokines - their pathogenic and therapeutic role in chronic viral hepatitis. Rev Esp Enferm Dig 2009, 101:343-351.
15. Kondo Y., Kobayashi K., Ueno Y., Shiina M., Niitsuma H., Kanno N., et al. Mechanism of T cell hiporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J Gastroenterol 2006, 12:4310-4317.
16. Kanzler S., Lohse A., Keil A., Henniger J., Dienes H.P., Schirmacher P., et al. TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999, 276:G1059-68.
17. Wells R.G. TGF-β signaling pathways. Am J Physiol Gastrointest Liver Physiol 2000, 279:G845-50.
18. Rees L.E.N., Wood N.A.P., Gillespie K.M., Lai K.N., Gaston K., Schirmacher P., et al. The interleukin-10 - 1082 G/A polymorphisms: allele frequency in different populations and functional significance. Cell Mol Life Sci 2000, 59:560-569.
19. Liu M., Cao B., Zhang H., Daí Y., Liu X., Xu C. Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection. Immunogenetics 2006, 58:859-864.
20. Hsieh Y., Chang C., Tsai F., Peng C., Yeh L., Lin C. Polymorphism for transforming growth factor beta 1-509 (TGF-B1-509): association with endometriosis. Biochem Genet 2005, 43:203-210.
21. Kiki I., Yilmaz O., Erdem F., Gundogdu M., Demircan B., Bilici M. Tumor necrosis factor-α levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores. Int J Clin Pract 2006, 60:1075-1079.
22. Migita K., Miyazoe S., Maeda Y., Daikoku M., Abiru S., Ueki T., et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-β1 polymorphisms and hepatocelular carcinoma. J Hepatol 2005, 42:505-510.
23. Cheong J.Y., Cho S.W., Chung S.G., Lee J.A., Yeo M., Wang H.J., et al. Genetic polymorphism of interferon-γ, interferon-γ receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet 2006, 44:246-255.
24. Du T., Guo X.H., Zhu X.L., Lu L.P., Gao C.Y., Li Z., et al. Association of TNF-α promoter polymorphisms with the outcome of hepatitis B virus infection in Chinese Han population. J Viral Hepat 2006, 13:618-624.
25. Abbott W., Gane E., Winship I., Munn S., Tukuitonga C. Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. Immunogenectis 2007, 59:187-195.
26. Shimizu I., Kohno N., Tamaki K., Shono M., Huang H.W., He J.H., et al. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol 2007, 13:4295-4305.
27. Ribeiro C.S.S., Visentainer J.E.L., Moliterno R.A. Association of cytokine genetic polymorphism with hepatitis B infection evolution in adult patients. Mem Inst Oswaldo Cruz 2007, 102:435-440.
28. Jeng J.E., Tsai J.F., Chuang L.Y., Ho M.S., Lin Z.Y., Hsieh M.Y., et al. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocelular carcinoma. Neoplasia 2007, 9:987-992.
29. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
30. Gao Q.J., Liu D.W., Zhang S.Y., Jia M., Wang L.M., Wu L.H., et al. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 2009, 15:5610-5619.
31. Yu H., Zhu Q.R., Gu S.Q., Fei L.E. Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBV infection. World J Gastroenterol 2006, 12:2928-2931.
32. Pravica V., Perrrey C., Stevens A., Lee J.H., Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 2000, 61:863-866.
33. Zhang L.J., Wang X.Z. Interleukin-10 and chronic liver disease. World J Gastroenterol 2006, 12:1681-1685.
34. Zhang P., Chen Z., Chen F., Li M.W., Fan J., Zhou H.M., et al. Expression of IFN-gamma and its receptor alpha in the peripheral blood of patients with chronic hepatitis C. Chin Med J 2004, 17:79-82.
35. Gramenzi A., Andreone P., Loggi E., Foschi F.G., Cursaro C., Margotti M., et al. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J Viral Hepat 2005, 12:525-530.